nodes	percent_of_prediction	percent_of_DWPC	metapath
Pimozide—CYP1A2—Carmustine—malignant glioma	0.138	0.569	CbGbCtD
Pimozide—CYP3A4—Temozolomide—malignant glioma	0.105	0.43	CbGbCtD
Pimozide—DRD3—telencephalic ventricle—malignant glioma	0.014	0.0586	CbGeAlD
Pimozide—HTR2A—choroid plexus—malignant glioma	0.0133	0.0558	CbGeAlD
Pimozide—Tonic-clonic seizures—Carmustine—malignant glioma	0.0112	0.0757	CcSEcCtD
Pimozide—OPRM1—telencephalic ventricle—malignant glioma	0.00887	0.0372	CbGeAlD
Pimozide—CALM2—pons—malignant glioma	0.00783	0.0328	CbGeAlD
Pimozide—Abnormal behaviour—Temozolomide—malignant glioma	0.0078	0.0529	CcSEcCtD
Pimozide—CALM1—pons—malignant glioma	0.00779	0.0326	CbGeAlD
Pimozide—HTR2A—cerebellar cortex—malignant glioma	0.00671	0.0281	CbGeAlD
Pimozide—HTR1A—telencephalic ventricle—malignant glioma	0.00655	0.0275	CbGeAlD
Pimozide—Grand mal convulsion—Carmustine—malignant glioma	0.00631	0.0428	CcSEcCtD
Pimozide—Faecal incontinence—Carmustine—malignant glioma	0.00596	0.0404	CcSEcCtD
Pimozide—DRD2—telencephalic ventricle—malignant glioma	0.00592	0.0248	CbGeAlD
Pimozide—Faecal incontinence—Temozolomide—malignant glioma	0.00576	0.039	CcSEcCtD
Pimozide—CALM2—pineal body—malignant glioma	0.00559	0.0234	CbGeAlD
Pimozide—CALM1—pineal body—malignant glioma	0.00556	0.0233	CbGeAlD
Pimozide—HTR2A—pons—malignant glioma	0.00475	0.0199	CbGeAlD
Pimozide—CACNA1G—telencephalon—malignant glioma	0.00472	0.0198	CbGeAlD
Pimozide—HTR2A—vertebral column—malignant glioma	0.00471	0.0197	CbGeAlD
Pimozide—HTR2A—telencephalic ventricle—malignant glioma	0.00391	0.0164	CbGeAlD
Pimozide—Extrapyramidal disorder—Temozolomide—malignant glioma	0.00386	0.0262	CcSEcCtD
Pimozide—Endocrine disorder—Temozolomide—malignant glioma	0.0035	0.0238	CcSEcCtD
Pimozide—Speech disorder—Carmustine—malignant glioma	0.0035	0.0237	CcSEcCtD
Pimozide—CALM2—endothelium—malignant glioma	0.00346	0.0145	CbGeAlD
Pimozide—CALM1—endothelium—malignant glioma	0.00344	0.0144	CbGeAlD
Pimozide—HTR2A—pineal body—malignant glioma	0.00339	0.0142	CbGeAlD
Pimozide—Speech disorder—Temozolomide—malignant glioma	0.00338	0.0229	CcSEcCtD
Pimozide—Amenorrhoea—Temozolomide—malignant glioma	0.00331	0.0224	CcSEcCtD
Pimozide—HTR6—telencephalon—malignant glioma	0.00324	0.0136	CbGeAlD
Pimozide—CALM2—blood vessel—malignant glioma	0.00319	0.0134	CbGeAlD
Pimozide—CALM1—blood vessel—malignant glioma	0.00317	0.0133	CbGeAlD
Pimozide—Aplastic anaemia—Temozolomide—malignant glioma	0.00273	0.0185	CcSEcCtD
Pimozide—Gynaecomastia—Carmustine—malignant glioma	0.00269	0.0182	CcSEcCtD
Pimozide—CACNA1G—central nervous system—malignant glioma	0.00268	0.0112	CbGeAlD
Pimozide—CACNA1G—cerebellum—malignant glioma	0.00262	0.011	CbGeAlD
Pimozide—OPRM1—brainstem—malignant glioma	0.0024	0.0101	CbGeAlD
Pimozide—Hyponatraemia—Carmustine—malignant glioma	0.00219	0.0149	CcSEcCtD
Pimozide—CALM3—retina—malignant glioma	0.00214	0.00897	CbGeAlD
Pimozide—OPRM1—telencephalon—malignant glioma	0.00213	0.00893	CbGeAlD
Pimozide—CACNA1G—brain—malignant glioma	0.00213	0.00892	CbGeAlD
Pimozide—HTR2A—endothelium—malignant glioma	0.0021	0.00878	CbGeAlD
Pimozide—CALM3—telencephalon—malignant glioma	0.00197	0.00825	CbGeAlD
Pimozide—CHRM2—telencephalon—malignant glioma	0.00194	0.00813	CbGeAlD
Pimozide—HTR2A—blood vessel—malignant glioma	0.00193	0.0081	CbGeAlD
Pimozide—DRD3—central nervous system—malignant glioma	0.00191	0.008	CbGeAlD
Pimozide—Breast disorder—Temozolomide—malignant glioma	0.00191	0.0129	CcSEcCtD
Pimozide—CALM2—embryo—malignant glioma	0.0019	0.00797	CbGeAlD
Pimozide—CALM1—embryo—malignant glioma	0.00189	0.00793	CbGeAlD
Pimozide—Dysphagia—Carmustine—malignant glioma	0.00189	0.0128	CcSEcCtD
Pimozide—HTR6—central nervous system—malignant glioma	0.00184	0.0077	CbGeAlD
Pimozide—Dysphagia—Temozolomide—malignant glioma	0.00182	0.0124	CcSEcCtD
Pimozide—Pancytopenia—Carmustine—malignant glioma	0.00179	0.0121	CcSEcCtD
Pimozide—HTR1A—brainstem—malignant glioma	0.00177	0.00743	CbGeAlD
Pimozide—CALM2—brainstem—malignant glioma	0.00174	0.0073	CbGeAlD
Pimozide—CALM1—brainstem—malignant glioma	0.00173	0.00727	CbGeAlD
Pimozide—Pancytopenia—Temozolomide—malignant glioma	0.00173	0.0117	CcSEcCtD
Pimozide—OPRK1—central nervous system—malignant glioma	0.0017	0.00713	CbGeAlD
Pimozide—Pollakiuria—Temozolomide—malignant glioma	0.00168	0.0114	CcSEcCtD
Pimozide—CALM2—retina—malignant glioma	0.00168	0.00704	CbGeAlD
Pimozide—Erectile dysfunction—Temozolomide—malignant glioma	0.00168	0.0114	CcSEcCtD
Pimozide—Depression—Carmustine—malignant glioma	0.00168	0.0114	CcSEcCtD
Pimozide—CALM1—retina—malignant glioma	0.00167	0.00701	CbGeAlD
Pimozide—OPRK1—cerebellum—malignant glioma	0.00166	0.00697	CbGeAlD
Pimozide—Weight increased—Temozolomide—malignant glioma	0.00166	0.0112	CcSEcCtD
Pimozide—Weight decreased—Temozolomide—malignant glioma	0.00165	0.0112	CcSEcCtD
Pimozide—Domperidone—CYP2B6—malignant glioma	0.00162	0.525	CrCbGaD
Pimozide—Depression—Temozolomide—malignant glioma	0.00162	0.011	CcSEcCtD
Pimozide—DRD2—brainstem—malignant glioma	0.0016	0.00671	CbGeAlD
Pimozide—HTR1A—telencephalon—malignant glioma	0.00157	0.00659	CbGeAlD
Pimozide—CALM3—medulla oblongata—malignant glioma	0.00155	0.00648	CbGeAlD
Pimozide—CALM2—telencephalon—malignant glioma	0.00155	0.00648	CbGeAlD
Pimozide—DRD2—retina—malignant glioma	0.00155	0.00648	CbGeAlD
Pimozide—CALM1—telencephalon—malignant glioma	0.00154	0.00645	CbGeAlD
Pimozide—OPRM1—midbrain—malignant glioma	0.00153	0.00641	CbGeAlD
Pimozide—DRD3—brain—malignant glioma	0.00152	0.00635	CbGeAlD
Pimozide—OPRM1—spinal cord—malignant glioma	0.00149	0.00625	CbGeAlD
Pimozide—Connective tissue disorder—Carmustine—malignant glioma	0.00148	0.0101	CcSEcCtD
Pimozide—Flunarizine—CYP2B6—malignant glioma	0.00147	0.475	CrCbGaD
Pimozide—HTR6—brain—malignant glioma	0.00146	0.00612	CbGeAlD
Pimozide—Visual impairment—Carmustine—malignant glioma	0.00145	0.00987	CcSEcCtD
Pimozide—Connective tissue disorder—Temozolomide—malignant glioma	0.00143	0.00972	CcSEcCtD
Pimozide—DRD2—telencephalon—malignant glioma	0.00142	0.00596	CbGeAlD
Pimozide—CALM3—midbrain—malignant glioma	0.00141	0.00592	CbGeAlD
Pimozide—Eye disorder—Carmustine—malignant glioma	0.00141	0.00957	CcSEcCtD
Pimozide—Visual impairment—Temozolomide—malignant glioma	0.00141	0.00954	CcSEcCtD
Pimozide—KCNH2—telencephalon—malignant glioma	0.0014	0.00587	CbGeAlD
Pimozide—CALM3—spinal cord—malignant glioma	0.00138	0.00578	CbGeAlD
Pimozide—Eye disorder—Temozolomide—malignant glioma	0.00136	0.00925	CcSEcCtD
Pimozide—Cardiac disorder—Temozolomide—malignant glioma	0.00135	0.00918	CcSEcCtD
Pimozide—OPRK1—brain—malignant glioma	0.00135	0.00566	CbGeAlD
Pimozide—Mental disorder—Carmustine—malignant glioma	0.00132	0.00897	CcSEcCtD
Pimozide—Mental disorder—Temozolomide—malignant glioma	0.00128	0.00867	CcSEcCtD
Pimozide—ABCB1—blood vessel—malignant glioma	0.00127	0.00531	CbGeAlD
Pimozide—Vision blurred—Carmustine—malignant glioma	0.00124	0.0084	CcSEcCtD
Pimozide—Tremor—Carmustine—malignant glioma	0.00123	0.00835	CcSEcCtD
Pimozide—CALM2—medulla oblongata—malignant glioma	0.00122	0.00509	CbGeAlD
Pimozide—Anaemia—Carmustine—malignant glioma	0.00121	0.00824	CcSEcCtD
Pimozide—OPRM1—central nervous system—malignant glioma	0.00121	0.00507	CbGeAlD
Pimozide—CALM1—medulla oblongata—malignant glioma	0.00121	0.00507	CbGeAlD
Pimozide—Agitation—Carmustine—malignant glioma	0.00121	0.00819	CcSEcCtD
Pimozide—Vision blurred—Temozolomide—malignant glioma	0.0012	0.00812	CcSEcCtD
Pimozide—Tremor—Temozolomide—malignant glioma	0.00119	0.00807	CcSEcCtD
Pimozide—Leukopenia—Carmustine—malignant glioma	0.00118	0.00798	CcSEcCtD
Pimozide—Anaemia—Temozolomide—malignant glioma	0.00117	0.00796	CcSEcCtD
Pimozide—Agitation—Temozolomide—malignant glioma	0.00117	0.00792	CcSEcCtD
Pimozide—HTR2A—embryo—malignant glioma	0.00115	0.00483	CbGeAlD
Pimozide—Convulsion—Carmustine—malignant glioma	0.00114	0.00772	CcSEcCtD
Pimozide—Leukopenia—Temozolomide—malignant glioma	0.00114	0.00771	CcSEcCtD
Pimozide—Hypertension—Carmustine—malignant glioma	0.00113	0.0077	CcSEcCtD
Pimozide—HTR1A—midbrain—malignant glioma	0.00113	0.00473	CbGeAlD
Pimozide—HRH1—telencephalon—malignant glioma	0.00112	0.0047	CbGeAlD
Pimozide—Palpitations—Temozolomide—malignant glioma	0.00112	0.00761	CcSEcCtD
Pimozide—Myalgia—Carmustine—malignant glioma	0.00112	0.00759	CcSEcCtD
Pimozide—Chest pain—Carmustine—malignant glioma	0.00112	0.00759	CcSEcCtD
Pimozide—CALM2—midbrain—malignant glioma	0.00111	0.00465	CbGeAlD
Pimozide—CALM1—midbrain—malignant glioma	0.00111	0.00463	CbGeAlD
Pimozide—HTR1A—spinal cord—malignant glioma	0.0011	0.00462	CbGeAlD
Pimozide—CHRM2—central nervous system—malignant glioma	0.0011	0.00462	CbGeAlD
Pimozide—KCNH2—medulla oblongata—malignant glioma	0.0011	0.00461	CbGeAlD
Pimozide—Convulsion—Temozolomide—malignant glioma	0.0011	0.00746	CcSEcCtD
Pimozide—Hypertension—Temozolomide—malignant glioma	0.0011	0.00744	CcSEcCtD
Pimozide—CALM3—cerebellum—malignant glioma	0.00109	0.00458	CbGeAlD
Pimozide—CALM2—spinal cord—malignant glioma	0.00108	0.00454	CbGeAlD
Pimozide—Myalgia—Temozolomide—malignant glioma	0.00108	0.00733	CcSEcCtD
Pimozide—CYP2E1—telencephalon—malignant glioma	0.00108	0.00452	CbGeAlD
Pimozide—CALM1—spinal cord—malignant glioma	0.00108	0.00452	CbGeAlD
Pimozide—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—malignant glioma	0.00107	0.00728	CcSEcCtD
Pimozide—Dry mouth—Temozolomide—malignant glioma	0.00106	0.00717	CcSEcCtD
Pimozide—HTR2A—brainstem—malignant glioma	0.00106	0.00443	CbGeAlD
Pimozide—Tachycardia—Carmustine—malignant glioma	0.00105	0.0071	CcSEcCtD
Pimozide—Anorexia—Carmustine—malignant glioma	0.00102	0.00693	CcSEcCtD
Pimozide—DRD2—midbrain—malignant glioma	0.00102	0.00428	CbGeAlD
Pimozide—HTR2A—retina—malignant glioma	0.00102	0.00427	CbGeAlD
Pimozide—Nervous system disorder—Temozolomide—malignant glioma	0.00102	0.00689	CcSEcCtD
Pimozide—Skin disorder—Temozolomide—malignant glioma	0.00101	0.00683	CcSEcCtD
Pimozide—KCNH2—midbrain—malignant glioma	0.00101	0.00421	CbGeAlD
Pimozide—Hypotension—Carmustine—malignant glioma	0.001	0.0068	CcSEcCtD
Pimozide—Hyperhidrosis—Temozolomide—malignant glioma	0.001	0.0068	CcSEcCtD
Pimozide—Anorexia—Temozolomide—malignant glioma	0.000988	0.0067	CcSEcCtD
Pimozide—KCNH2—spinal cord—malignant glioma	0.000982	0.00411	CbGeAlD
Pimozide—Musculoskeletal discomfort—Carmustine—malignant glioma	0.000977	0.00663	CcSEcCtD
Pimozide—Insomnia—Carmustine—malignant glioma	0.00097	0.00658	CcSEcCtD
Pimozide—CYP2D6—brainstem—malignant glioma	0.000963	0.00403	CbGeAlD
Pimozide—OPRM1—brain—malignant glioma	0.000962	0.00403	CbGeAlD
Pimozide—Somnolence—Carmustine—malignant glioma	0.000954	0.00647	CcSEcCtD
Pimozide—Musculoskeletal discomfort—Temozolomide—malignant glioma	0.000944	0.0064	CcSEcCtD
Pimozide—HTR2A—telencephalon—malignant glioma	0.000938	0.00393	CbGeAlD
Pimozide—Insomnia—Temozolomide—malignant glioma	0.000937	0.00636	CcSEcCtD
Pimozide—Decreased appetite—Carmustine—malignant glioma	0.000932	0.00632	CcSEcCtD
Pimozide—Gastrointestinal disorder—Carmustine—malignant glioma	0.000926	0.00628	CcSEcCtD
Pimozide—Somnolence—Temozolomide—malignant glioma	0.000921	0.00625	CcSEcCtD
Pimozide—Constipation—Carmustine—malignant glioma	0.000917	0.00622	CcSEcCtD
Pimozide—Decreased appetite—Temozolomide—malignant glioma	0.000901	0.00611	CcSEcCtD
Pimozide—Gastrointestinal disorder—Temozolomide—malignant glioma	0.000895	0.00607	CcSEcCtD
Pimozide—HTR1A—central nervous system—malignant glioma	0.000894	0.00375	CbGeAlD
Pimozide—CALM3—brain—malignant glioma	0.000889	0.00372	CbGeAlD
Pimozide—Constipation—Temozolomide—malignant glioma	0.000886	0.00601	CcSEcCtD
Pimozide—CALM2—central nervous system—malignant glioma	0.000879	0.00368	CbGeAlD
Pimozide—CHRM2—brain—malignant glioma	0.000875	0.00367	CbGeAlD
Pimozide—CALM1—central nervous system—malignant glioma	0.000875	0.00367	CbGeAlD
Pimozide—HTR1A—cerebellum—malignant glioma	0.000874	0.00366	CbGeAlD
Pimozide—CALM2—cerebellum—malignant glioma	0.000859	0.0036	CbGeAlD
Pimozide—CALM1—cerebellum—malignant glioma	0.000855	0.00358	CbGeAlD
Pimozide—CYP2D6—telencephalon—malignant glioma	0.000854	0.00358	CbGeAlD
Pimozide—CYP2E1—medulla oblongata—malignant glioma	0.000848	0.00355	CbGeAlD
Pimozide—Urticaria—Temozolomide—malignant glioma	0.000823	0.00558	CcSEcCtD
Pimozide—DRD2—central nervous system—malignant glioma	0.000808	0.00339	CbGeAlD
Pimozide—KCNH2—central nervous system—malignant glioma	0.000796	0.00334	CbGeAlD
Pimozide—DRD2—cerebellum—malignant glioma	0.00079	0.00331	CbGeAlD
Pimozide—KCNH2—cerebellum—malignant glioma	0.000778	0.00326	CbGeAlD
Pimozide—Asthenia—Carmustine—malignant glioma	0.00077	0.00522	CcSEcCtD
Pimozide—CYP2E1—spinal cord—malignant glioma	0.000756	0.00317	CbGeAlD
Pimozide—ABCB1—embryo—malignant glioma	0.000756	0.00317	CbGeAlD
Pimozide—Asthenia—Temozolomide—malignant glioma	0.000744	0.00504	CcSEcCtD
Pimozide—HTR2A—medulla oblongata—malignant glioma	0.000737	0.00309	CbGeAlD
Pimozide—Diarrhoea—Carmustine—malignant glioma	0.000734	0.00498	CcSEcCtD
Pimozide—Pruritus—Temozolomide—malignant glioma	0.000733	0.00497	CcSEcCtD
Pimozide—HTR1A—brain—malignant glioma	0.00071	0.00297	CbGeAlD
Pimozide—Dizziness—Carmustine—malignant glioma	0.000709	0.00481	CcSEcCtD
Pimozide—Diarrhoea—Temozolomide—malignant glioma	0.000709	0.00481	CcSEcCtD
Pimozide—CALM2—brain—malignant glioma	0.000698	0.00292	CbGeAlD
Pimozide—CALM1—brain—malignant glioma	0.000695	0.00291	CbGeAlD
Pimozide—Dizziness—Temozolomide—malignant glioma	0.000685	0.00465	CcSEcCtD
Pimozide—Vomiting—Carmustine—malignant glioma	0.000682	0.00463	CcSEcCtD
Pimozide—Rash—Carmustine—malignant glioma	0.000676	0.00459	CcSEcCtD
Pimozide—Dermatitis—Carmustine—malignant glioma	0.000676	0.00458	CcSEcCtD
Pimozide—HTR2A—midbrain—malignant glioma	0.000673	0.00282	CbGeAlD
Pimozide—Headache—Carmustine—malignant glioma	0.000672	0.00456	CcSEcCtD
Pimozide—ABCB1—retina—malignant glioma	0.000668	0.0028	CbGeAlD
Pimozide—Vomiting—Temozolomide—malignant glioma	0.000659	0.00447	CcSEcCtD
Pimozide—HTR2A—spinal cord—malignant glioma	0.000657	0.00275	CbGeAlD
Pimozide—Rash—Temozolomide—malignant glioma	0.000654	0.00443	CcSEcCtD
Pimozide—Dermatitis—Temozolomide—malignant glioma	0.000653	0.00443	CcSEcCtD
Pimozide—Headache—Temozolomide—malignant glioma	0.000649	0.0044	CcSEcCtD
Pimozide—DRD2—brain—malignant glioma	0.000642	0.00269	CbGeAlD
Pimozide—HRH1—central nervous system—malignant glioma	0.000638	0.00267	CbGeAlD
Pimozide—Nausea—Carmustine—malignant glioma	0.000637	0.00432	CcSEcCtD
Pimozide—KCNH2—brain—malignant glioma	0.000632	0.00265	CbGeAlD
Pimozide—Nausea—Temozolomide—malignant glioma	0.000616	0.00418	CcSEcCtD
Pimozide—ABCB1—telencephalon—malignant glioma	0.000615	0.00257	CbGeAlD
Pimozide—CYP2E1—central nervous system—malignant glioma	0.000613	0.00257	CbGeAlD
Pimozide—CYP2E1—cerebellum—malignant glioma	0.000599	0.00251	CbGeAlD
Pimozide—HTR2A—central nervous system—malignant glioma	0.000533	0.00223	CbGeAlD
Pimozide—HTR2A—cerebellum—malignant glioma	0.000521	0.00218	CbGeAlD
Pimozide—HRH1—brain—malignant glioma	0.000507	0.00212	CbGeAlD
Pimozide—CYP3A4—central nervous system—malignant glioma	0.000493	0.00207	CbGeAlD
Pimozide—CYP2E1—brain—malignant glioma	0.000487	0.00204	CbGeAlD
Pimozide—CYP2D6—central nervous system—malignant glioma	0.000486	0.00203	CbGeAlD
Pimozide—ABCB1—medulla oblongata—malignant glioma	0.000483	0.00202	CbGeAlD
Pimozide—CYP2D6—cerebellum—malignant glioma	0.000475	0.00199	CbGeAlD
Pimozide—ABCB1—midbrain—malignant glioma	0.000441	0.00185	CbGeAlD
Pimozide—ABCB1—spinal cord—malignant glioma	0.000431	0.0018	CbGeAlD
Pimozide—HTR2A—brain—malignant glioma	0.000423	0.00177	CbGeAlD
Pimozide—CYP2D6—brain—malignant glioma	0.000386	0.00162	CbGeAlD
Pimozide—ABCB1—central nervous system—malignant glioma	0.000349	0.00146	CbGeAlD
Pimozide—ABCB1—cerebellum—malignant glioma	0.000341	0.00143	CbGeAlD
Pimozide—ABCB1—brain—malignant glioma	0.000277	0.00116	CbGeAlD
Pimozide—OPRM1—Signaling Pathways—MYC—malignant glioma	9.1e-06	2.47e-05	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—CXCL8—malignant glioma	9.08e-06	2.47e-05	CbGpPWpGaD
Pimozide—CALM1—Metabolism—PIK3CB—malignant glioma	9.07e-06	2.47e-05	CbGpPWpGaD
Pimozide—CALM2—Metabolism—PIK3CB—malignant glioma	9.07e-06	2.47e-05	CbGpPWpGaD
Pimozide—CALM2—Immune System—STAT3—malignant glioma	9.07e-06	2.46e-05	CbGpPWpGaD
Pimozide—CALM1—Immune System—STAT3—malignant glioma	9.07e-06	2.46e-05	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—CXCL8—malignant glioma	9.06e-06	2.46e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—AKT2—malignant glioma	9.06e-06	2.46e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—AKT2—malignant glioma	9.06e-06	2.46e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling by GPCR—EGFR—malignant glioma	9.02e-06	2.45e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling by GPCR—EGFR—malignant glioma	9.02e-06	2.45e-05	CbGpPWpGaD
Pimozide—DRD3—Signaling Pathways—MYC—malignant glioma	9.01e-06	2.45e-05	CbGpPWpGaD
Pimozide—HTR6—Signaling Pathways—PIK3CA—malignant glioma	9.01e-06	2.45e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—PIK3CD—malignant glioma	9e-06	2.45e-05	CbGpPWpGaD
Pimozide—CALM1—Metabolism—PTGS2—malignant glioma	8.99e-06	2.44e-05	CbGpPWpGaD
Pimozide—CALM2—Metabolism—PTGS2—malignant glioma	8.99e-06	2.44e-05	CbGpPWpGaD
Pimozide—ABCB1—Metabolism—PPARG—malignant glioma	8.95e-06	2.43e-05	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—CXCL8—malignant glioma	8.91e-06	2.42e-05	CbGpPWpGaD
Pimozide—DRD2—GPCR downstream signaling—AKT1—malignant glioma	8.91e-06	2.42e-05	CbGpPWpGaD
Pimozide—OPRM1—Signaling Pathways—EGFR—malignant glioma	8.9e-06	2.42e-05	CbGpPWpGaD
Pimozide—OPRK1—Signaling Pathways—TP53—malignant glioma	8.84e-06	2.4e-05	CbGpPWpGaD
Pimozide—DRD2—Signaling Pathways—CASP3—malignant glioma	8.83e-06	2.4e-05	CbGpPWpGaD
Pimozide—DRD2—Signaling Pathways—IL2—malignant glioma	8.82e-06	2.4e-05	CbGpPWpGaD
Pimozide—DRD3—Signaling Pathways—EGFR—malignant glioma	8.81e-06	2.4e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling by GPCR—KRAS—malignant glioma	8.81e-06	2.39e-05	CbGpPWpGaD
Pimozide—HTR2A—GPCR downstream signaling—AKT1—malignant glioma	8.77e-06	2.38e-05	CbGpPWpGaD
Pimozide—HRH1—GPCR downstream signaling—AKT1—malignant glioma	8.75e-06	2.38e-05	CbGpPWpGaD
Pimozide—CYP2D6—Metabolism—PIK3CG—malignant glioma	8.74e-06	2.38e-05	CbGpPWpGaD
Pimozide—HTR6—Signaling Pathways—TP53—malignant glioma	8.71e-06	2.37e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—PIK3CD—malignant glioma	8.7e-06	2.37e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—PIK3CD—malignant glioma	8.7e-06	2.37e-05	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—CASP3—malignant glioma	8.69e-06	2.36e-05	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—IL2—malignant glioma	8.68e-06	2.36e-05	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—CASP3—malignant glioma	8.67e-06	2.36e-05	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—IL2—malignant glioma	8.66e-06	2.35e-05	CbGpPWpGaD
Pimozide—CALM3—Disease—STAT3—malignant glioma	8.66e-06	2.35e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—FGF2—malignant glioma	8.62e-06	2.34e-05	CbGpPWpGaD
Pimozide—CHRM2—GPCR downstream signaling—AKT1—malignant glioma	8.61e-06	2.34e-05	CbGpPWpGaD
Pimozide—HTR1A—Signaling Pathways—VEGFA—malignant glioma	8.54e-06	2.32e-05	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—CASP3—malignant glioma	8.53e-06	2.32e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling by GPCR—KRAS—malignant glioma	8.52e-06	2.32e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling by GPCR—KRAS—malignant glioma	8.52e-06	2.32e-05	CbGpPWpGaD
Pimozide—CALM3—Immune System—EGFR—malignant glioma	8.52e-06	2.32e-05	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—IL2—malignant glioma	8.52e-06	2.32e-05	CbGpPWpGaD
Pimozide—HTR1A—Signaling Pathways—STAT3—malignant glioma	8.45e-06	2.3e-05	CbGpPWpGaD
Pimozide—CYP2D6—Metabolism—PPARG—malignant glioma	8.44e-06	2.29e-05	CbGpPWpGaD
Pimozide—OPRM1—Signaling Pathways—KRAS—malignant glioma	8.41e-06	2.29e-05	CbGpPWpGaD
Pimozide—CYP3A4—Metabolism—GSTP1—malignant glioma	8.38e-06	2.28e-05	CbGpPWpGaD
Pimozide—CALM1—Disease—STAT3—malignant glioma	8.37e-06	2.28e-05	CbGpPWpGaD
Pimozide—CALM2—Disease—STAT3—malignant glioma	8.37e-06	2.28e-05	CbGpPWpGaD
Pimozide—CYP2C19—Metabolism—PIK3CD—malignant glioma	8.36e-06	2.27e-05	CbGpPWpGaD
Pimozide—DRD2—Signaling Pathways—MMP9—malignant glioma	8.35e-06	2.27e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—FGF2—malignant glioma	8.33e-06	2.27e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—FGF2—malignant glioma	8.33e-06	2.27e-05	CbGpPWpGaD
Pimozide—DRD3—Signaling Pathways—KRAS—malignant glioma	8.33e-06	2.26e-05	CbGpPWpGaD
Pimozide—DRD2—Signaling Pathways—PTEN—malignant glioma	8.3e-06	2.26e-05	CbGpPWpGaD
Pimozide—CALM1—Immune System—EGFR—malignant glioma	8.24e-06	2.24e-05	CbGpPWpGaD
Pimozide—CALM2—Immune System—EGFR—malignant glioma	8.24e-06	2.24e-05	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—MMP9—malignant glioma	8.21e-06	2.23e-05	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—MMP9—malignant glioma	8.19e-06	2.23e-05	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—PTEN—malignant glioma	8.16e-06	2.22e-05	CbGpPWpGaD
Pimozide—CYP2E1—Metabolism—PTEN—malignant glioma	8.16e-06	2.22e-05	CbGpPWpGaD
Pimozide—ABCB1—Metabolism—PIK3CD—malignant glioma	8.16e-06	2.22e-05	CbGpPWpGaD
Pimozide—CYP3A4—Metabolism—CAT—malignant glioma	8.15e-06	2.22e-05	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—PTEN—malignant glioma	8.15e-06	2.21e-05	CbGpPWpGaD
Pimozide—CYP3A5—Metabolism—PTEN—malignant glioma	8.14e-06	2.21e-05	CbGpPWpGaD
Pimozide—CYP1A2—Metabolism—CAV1—malignant glioma	8.13e-06	2.21e-05	CbGpPWpGaD
Pimozide—CALM3—Metabolism—PTEN—malignant glioma	8.11e-06	2.2e-05	CbGpPWpGaD
Pimozide—DRD2—Signaling by GPCR—AKT1—malignant glioma	8.09e-06	2.2e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling by GPCR—PIK3CA—malignant glioma	8.09e-06	2.2e-05	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—MMP9—malignant glioma	8.06e-06	2.19e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—MDM2—malignant glioma	8.06e-06	2.19e-05	CbGpPWpGaD
Pimozide—CALM3—Immune System—KRAS—malignant glioma	8.05e-06	2.19e-05	CbGpPWpGaD
Pimozide—CALM3—Disease—MYC—malignant glioma	8.04e-06	2.19e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—RAF1—malignant glioma	8.03e-06	2.18e-05	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—PTEN—malignant glioma	8.02e-06	2.18e-05	CbGpPWpGaD
Pimozide—HTR2A—Signaling by GPCR—AKT1—malignant glioma	7.96e-06	2.16e-05	CbGpPWpGaD
Pimozide—HRH1—Signaling by GPCR—AKT1—malignant glioma	7.95e-06	2.16e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—ERBB2—malignant glioma	7.95e-06	2.16e-05	CbGpPWpGaD
Pimozide—CYP3A7—Metabolism—PIK3CA—malignant glioma	7.94e-06	2.16e-05	CbGpPWpGaD
Pimozide—CALM3—Disease—EGFR—malignant glioma	7.87e-06	2.14e-05	CbGpPWpGaD
Pimozide—HTR1A—Signaling Pathways—MYC—malignant glioma	7.85e-06	2.13e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—PIK3CB—malignant glioma	7.84e-06	2.13e-05	CbGpPWpGaD
Pimozide—CALM2—Metabolism—PTEN—malignant glioma	7.84e-06	2.13e-05	CbGpPWpGaD
Pimozide—CALM1—Metabolism—PTEN—malignant glioma	7.84e-06	2.13e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling by GPCR—PIK3CA—malignant glioma	7.83e-06	2.13e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling by GPCR—PIK3CA—malignant glioma	7.83e-06	2.13e-05	CbGpPWpGaD
Pimozide—CHRM2—Signaling by GPCR—AKT1—malignant glioma	7.82e-06	2.13e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—MDM2—malignant glioma	7.8e-06	2.12e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—MDM2—malignant glioma	7.8e-06	2.12e-05	CbGpPWpGaD
Pimozide—CALM2—Immune System—KRAS—malignant glioma	7.79e-06	2.12e-05	CbGpPWpGaD
Pimozide—CALM1—Immune System—KRAS—malignant glioma	7.79e-06	2.12e-05	CbGpPWpGaD
Pimozide—CALM1—Disease—MYC—malignant glioma	7.78e-06	2.11e-05	CbGpPWpGaD
Pimozide—CALM2—Disease—MYC—malignant glioma	7.78e-06	2.11e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—RAF1—malignant glioma	7.77e-06	2.11e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—RAF1—malignant glioma	7.77e-06	2.11e-05	CbGpPWpGaD
Pimozide—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	7.77e-06	2.11e-05	CbGpPWpGaD
Pimozide—OPRM1—Signaling Pathways—PIK3CA—malignant glioma	7.72e-06	2.1e-05	CbGpPWpGaD
Pimozide—CYP3A4—Metabolism—NCOR1—malignant glioma	7.7e-06	2.09e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—ERBB2—malignant glioma	7.69e-06	2.09e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—ERBB2—malignant glioma	7.69e-06	2.09e-05	CbGpPWpGaD
Pimozide—CYP2D6—Metabolism—PIK3CD—malignant glioma	7.69e-06	2.09e-05	CbGpPWpGaD
Pimozide—HTR1A—Signaling Pathways—EGFR—malignant glioma	7.68e-06	2.09e-05	CbGpPWpGaD
Pimozide—DRD3—Signaling Pathways—PIK3CA—malignant glioma	7.65e-06	2.08e-05	CbGpPWpGaD
Pimozide—CALM1—Disease—EGFR—malignant glioma	7.61e-06	2.07e-05	CbGpPWpGaD
Pimozide—CALM2—Disease—EGFR—malignant glioma	7.61e-06	2.07e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—PIK3CB—malignant glioma	7.59e-06	2.06e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—PIK3CB—malignant glioma	7.59e-06	2.06e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—CXCL8—malignant glioma	7.54e-06	2.05e-05	CbGpPWpGaD
Pimozide—DRD2—Signaling Pathways—VEGFA—malignant glioma	7.49e-06	2.04e-05	CbGpPWpGaD
Pimozide—OPRM1—Signaling Pathways—TP53—malignant glioma	7.47e-06	2.03e-05	CbGpPWpGaD
Pimozide—OPRK1—Signaling Pathways—AKT1—malignant glioma	7.47e-06	2.03e-05	CbGpPWpGaD
Pimozide—CALM3—Disease—KRAS—malignant glioma	7.43e-06	2.02e-05	CbGpPWpGaD
Pimozide—DRD2—Signaling Pathways—STAT3—malignant glioma	7.42e-06	2.02e-05	CbGpPWpGaD
Pimozide—CYP1A2—Metabolism—PIK3CG—malignant glioma	7.41e-06	2.01e-05	CbGpPWpGaD
Pimozide—DRD3—Signaling Pathways—TP53—malignant glioma	7.4e-06	2.01e-05	CbGpPWpGaD
Pimozide—CALM3—Immune System—PIK3CA—malignant glioma	7.39e-06	2.01e-05	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—VEGFA—malignant glioma	7.37e-06	2e-05	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—VEGFA—malignant glioma	7.36e-06	2e-05	CbGpPWpGaD
Pimozide—HTR6—Signaling Pathways—AKT1—malignant glioma	7.36e-06	2e-05	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—STAT3—malignant glioma	7.3e-06	1.98e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—CXCL8—malignant glioma	7.29e-06	1.98e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—CXCL8—malignant glioma	7.29e-06	1.98e-05	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—STAT3—malignant glioma	7.29e-06	1.98e-05	CbGpPWpGaD
Pimozide—CYP2C19—Metabolism—PIK3CB—malignant glioma	7.28e-06	1.98e-05	CbGpPWpGaD
Pimozide—HTR1A—Signaling Pathways—KRAS—malignant glioma	7.26e-06	1.97e-05	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—VEGFA—malignant glioma	7.24e-06	1.97e-05	CbGpPWpGaD
Pimozide—CYP2C19—Metabolism—PTGS2—malignant glioma	7.22e-06	1.96e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—CASP3—malignant glioma	7.21e-06	1.96e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—IL2—malignant glioma	7.2e-06	1.96e-05	CbGpPWpGaD
Pimozide—CALM1—Disease—KRAS—malignant glioma	7.19e-06	1.95e-05	CbGpPWpGaD
Pimozide—CALM2—Disease—KRAS—malignant glioma	7.19e-06	1.95e-05	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—STAT3—malignant glioma	7.17e-06	1.95e-05	CbGpPWpGaD
Pimozide—CALM2—Immune System—PIK3CA—malignant glioma	7.15e-06	1.94e-05	CbGpPWpGaD
Pimozide—CALM1—Immune System—PIK3CA—malignant glioma	7.15e-06	1.94e-05	CbGpPWpGaD
Pimozide—CYP1A2—Metabolism—PPARG—malignant glioma	7.15e-06	1.94e-05	CbGpPWpGaD
Pimozide—ABCB1—Metabolism—PIK3CB—malignant glioma	7.11e-06	1.93e-05	CbGpPWpGaD
Pimozide—ABCB1—Metabolism—PTGS2—malignant glioma	7.04e-06	1.91e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—CASP3—malignant glioma	6.98e-06	1.9e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—CASP3—malignant glioma	6.98e-06	1.9e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—IL2—malignant glioma	6.97e-06	1.89e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—IL2—malignant glioma	6.97e-06	1.89e-05	CbGpPWpGaD
Pimozide—DRD2—Signaling Pathways—MYC—malignant glioma	6.9e-06	1.87e-05	CbGpPWpGaD
Pimozide—CALM3—Disease—PIK3CA—malignant glioma	6.83e-06	1.86e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—MMP9—malignant glioma	6.82e-06	1.85e-05	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—MYC—malignant glioma	6.78e-06	1.84e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—PTEN—malignant glioma	6.78e-06	1.84e-05	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—MYC—malignant glioma	6.77e-06	1.84e-05	CbGpPWpGaD
Pimozide—DRD2—Signaling Pathways—EGFR—malignant glioma	6.74e-06	1.83e-05	CbGpPWpGaD
Pimozide—CYP2D6—Metabolism—PIK3CB—malignant glioma	6.7e-06	1.82e-05	CbGpPWpGaD
Pimozide—HTR1A—Signaling Pathways—PIK3CA—malignant glioma	6.67e-06	1.81e-05	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—MYC—malignant glioma	6.66e-06	1.81e-05	CbGpPWpGaD
Pimozide—CYP2D6—Metabolism—PTGS2—malignant glioma	6.64e-06	1.8e-05	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—EGFR—malignant glioma	6.64e-06	1.8e-05	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—EGFR—malignant glioma	6.62e-06	1.8e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling by GPCR—AKT1—malignant glioma	6.61e-06	1.8e-05	CbGpPWpGaD
Pimozide—CALM2—Disease—PIK3CA—malignant glioma	6.6e-06	1.8e-05	CbGpPWpGaD
Pimozide—CALM1—Disease—PIK3CA—malignant glioma	6.6e-06	1.8e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—MMP9—malignant glioma	6.59e-06	1.79e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—MMP9—malignant glioma	6.59e-06	1.79e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—PTEN—malignant glioma	6.56e-06	1.78e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—PTEN—malignant glioma	6.56e-06	1.78e-05	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—EGFR—malignant glioma	6.52e-06	1.77e-05	CbGpPWpGaD
Pimozide—CYP1A2—Metabolism—PIK3CD—malignant glioma	6.51e-06	1.77e-05	CbGpPWpGaD
Pimozide—CYP3A7—Metabolism—AKT1—malignant glioma	6.49e-06	1.76e-05	CbGpPWpGaD
Pimozide—HTR1A—Signaling Pathways—TP53—malignant glioma	6.45e-06	1.75e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling by GPCR—AKT1—malignant glioma	6.4e-06	1.74e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling by GPCR—AKT1—malignant glioma	6.4e-06	1.74e-05	CbGpPWpGaD
Pimozide—DRD2—Signaling Pathways—KRAS—malignant glioma	6.37e-06	1.73e-05	CbGpPWpGaD
Pimozide—OPRM1—Signaling Pathways—AKT1—malignant glioma	6.31e-06	1.72e-05	CbGpPWpGaD
Pimozide—CYP2C19—Metabolism—PTEN—malignant glioma	6.29e-06	1.71e-05	CbGpPWpGaD
Pimozide—CYP3A4—Metabolism—CAV1—malignant glioma	6.27e-06	1.71e-05	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—KRAS—malignant glioma	6.27e-06	1.7e-05	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—KRAS—malignant glioma	6.26e-06	1.7e-05	CbGpPWpGaD
Pimozide—DRD3—Signaling Pathways—AKT1—malignant glioma	6.25e-06	1.7e-05	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—KRAS—malignant glioma	6.16e-06	1.67e-05	CbGpPWpGaD
Pimozide—ABCB1—Metabolism—PTEN—malignant glioma	6.14e-06	1.67e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—VEGFA—malignant glioma	6.12e-06	1.66e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—STAT3—malignant glioma	6.06e-06	1.65e-05	CbGpPWpGaD
Pimozide—CALM3—Immune System—AKT1—malignant glioma	6.04e-06	1.64e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—VEGFA—malignant glioma	5.92e-06	1.61e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—VEGFA—malignant glioma	5.92e-06	1.61e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—STAT3—malignant glioma	5.86e-06	1.59e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—STAT3—malignant glioma	5.86e-06	1.59e-05	CbGpPWpGaD
Pimozide—DRD2—Signaling Pathways—PIK3CA—malignant glioma	5.85e-06	1.59e-05	CbGpPWpGaD
Pimozide—CALM2—Immune System—AKT1—malignant glioma	5.84e-06	1.59e-05	CbGpPWpGaD
Pimozide—CALM1—Immune System—AKT1—malignant glioma	5.84e-06	1.59e-05	CbGpPWpGaD
Pimozide—CYP2D6—Metabolism—PTEN—malignant glioma	5.79e-06	1.57e-05	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—PIK3CA—malignant glioma	5.76e-06	1.57e-05	CbGpPWpGaD
Pimozide—CYP2E1—Metabolism—PIK3CA—malignant glioma	5.75e-06	1.56e-05	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—PIK3CA—malignant glioma	5.75e-06	1.56e-05	CbGpPWpGaD
Pimozide—CYP3A5—Metabolism—PIK3CA—malignant glioma	5.74e-06	1.56e-05	CbGpPWpGaD
Pimozide—CALM3—Metabolism—PIK3CA—malignant glioma	5.72e-06	1.55e-05	CbGpPWpGaD
Pimozide—CYP3A4—Metabolism—PIK3CG—malignant glioma	5.72e-06	1.55e-05	CbGpPWpGaD
Pimozide—CYP1A2—Metabolism—PIK3CB—malignant glioma	5.67e-06	1.54e-05	CbGpPWpGaD
Pimozide—DRD2—Signaling Pathways—TP53—malignant glioma	5.66e-06	1.54e-05	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—PIK3CA—malignant glioma	5.66e-06	1.54e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—MYC—malignant glioma	5.63e-06	1.53e-05	CbGpPWpGaD
Pimozide—CYP1A2—Metabolism—PTGS2—malignant glioma	5.62e-06	1.53e-05	CbGpPWpGaD
Pimozide—CALM3—Disease—AKT1—malignant glioma	5.58e-06	1.52e-05	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—TP53—malignant glioma	5.57e-06	1.51e-05	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—TP53—malignant glioma	5.56e-06	1.51e-05	CbGpPWpGaD
Pimozide—CALM2—Metabolism—PIK3CA—malignant glioma	5.53e-06	1.5e-05	CbGpPWpGaD
Pimozide—CALM1—Metabolism—PIK3CA—malignant glioma	5.53e-06	1.5e-05	CbGpPWpGaD
Pimozide—CYP3A4—Metabolism—PPARG—malignant glioma	5.52e-06	1.5e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—EGFR—malignant glioma	5.51e-06	1.5e-05	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—TP53—malignant glioma	5.47e-06	1.49e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—MYC—malignant glioma	5.45e-06	1.48e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—MYC—malignant glioma	5.45e-06	1.48e-05	CbGpPWpGaD
Pimozide—HTR1A—Signaling Pathways—AKT1—malignant glioma	5.45e-06	1.48e-05	CbGpPWpGaD
Pimozide—CALM2—Disease—AKT1—malignant glioma	5.4e-06	1.47e-05	CbGpPWpGaD
Pimozide—CALM1—Disease—AKT1—malignant glioma	5.4e-06	1.47e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—EGFR—malignant glioma	5.33e-06	1.45e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—EGFR—malignant glioma	5.33e-06	1.45e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—KRAS—malignant glioma	5.2e-06	1.41e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—KRAS—malignant glioma	5.03e-06	1.37e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—KRAS—malignant glioma	5.03e-06	1.37e-05	CbGpPWpGaD
Pimozide—CYP3A4—Metabolism—PIK3CD—malignant glioma	5.02e-06	1.37e-05	CbGpPWpGaD
Pimozide—CYP1A2—Metabolism—PTEN—malignant glioma	4.9e-06	1.33e-05	CbGpPWpGaD
Pimozide—DRD2—Signaling Pathways—AKT1—malignant glioma	4.78e-06	1.3e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—PIK3CA—malignant glioma	4.78e-06	1.3e-05	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—AKT1—malignant glioma	4.71e-06	1.28e-05	CbGpPWpGaD
Pimozide—CYP2E1—Metabolism—AKT1—malignant glioma	4.7e-06	1.28e-05	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—AKT1—malignant glioma	4.69e-06	1.28e-05	CbGpPWpGaD
Pimozide—CYP3A5—Metabolism—AKT1—malignant glioma	4.69e-06	1.28e-05	CbGpPWpGaD
Pimozide—CALM3—Metabolism—AKT1—malignant glioma	4.67e-06	1.27e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—TP53—malignant glioma	4.63e-06	1.26e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—PIK3CA—malignant glioma	4.63e-06	1.26e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—PIK3CA—malignant glioma	4.63e-06	1.26e-05	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—AKT1—malignant glioma	4.62e-06	1.26e-05	CbGpPWpGaD
Pimozide—CALM1—Metabolism—AKT1—malignant glioma	4.52e-06	1.23e-05	CbGpPWpGaD
Pimozide—CALM2—Metabolism—AKT1—malignant glioma	4.52e-06	1.23e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—TP53—malignant glioma	4.47e-06	1.22e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—TP53—malignant glioma	4.47e-06	1.22e-05	CbGpPWpGaD
Pimozide—CYP2C19—Metabolism—PIK3CA—malignant glioma	4.44e-06	1.21e-05	CbGpPWpGaD
Pimozide—CYP3A4—Metabolism—PIK3CB—malignant glioma	4.38e-06	1.19e-05	CbGpPWpGaD
Pimozide—CYP3A4—Metabolism—PTGS2—malignant glioma	4.34e-06	1.18e-05	CbGpPWpGaD
Pimozide—ABCB1—Metabolism—PIK3CA—malignant glioma	4.33e-06	1.18e-05	CbGpPWpGaD
Pimozide—CYP2D6—Metabolism—PIK3CA—malignant glioma	4.08e-06	1.11e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—AKT1—malignant glioma	3.91e-06	1.06e-05	CbGpPWpGaD
Pimozide—CYP3A4—Metabolism—PTEN—malignant glioma	3.78e-06	1.03e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—AKT1—malignant glioma	3.78e-06	1.03e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—AKT1—malignant glioma	3.78e-06	1.03e-05	CbGpPWpGaD
Pimozide—CYP2C19—Metabolism—AKT1—malignant glioma	3.63e-06	9.86e-06	CbGpPWpGaD
Pimozide—ABCB1—Metabolism—AKT1—malignant glioma	3.54e-06	9.62e-06	CbGpPWpGaD
Pimozide—CYP1A2—Metabolism—PIK3CA—malignant glioma	3.46e-06	9.4e-06	CbGpPWpGaD
Pimozide—CYP2D6—Metabolism—AKT1—malignant glioma	3.34e-06	9.07e-06	CbGpPWpGaD
Pimozide—CYP1A2—Metabolism—AKT1—malignant glioma	2.83e-06	7.68e-06	CbGpPWpGaD
Pimozide—CYP3A4—Metabolism—PIK3CA—malignant glioma	2.67e-06	7.26e-06	CbGpPWpGaD
Pimozide—CYP3A4—Metabolism—AKT1—malignant glioma	2.18e-06	5.93e-06	CbGpPWpGaD
